Digitization and Patient Safety Where do we stand?

被引:0
|
作者
Weigand, Marcel [1 ]
机构
[1] Nehringstr 27, D-14059 Berlin, Germany
关键词
D O I
10.1016/j.zefq.2019.05.005
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:21 / 21
页数:1
相关论文
共 50 条
  • [1] Safety of stiripentol, where do we stand?
    Boyer, Olivia
    Hogan, Julien
    Dossier, Claire
    Charbit, Marina
    Biebuyck-Gouge, Nathalie
    Knebelmann, Bertrand
    Letavernier, Emmanuel
    PEDIATRIC NEPHROLOGY, 2023, 38 (07) : 2286 - 2286
  • [2] Assessment of Three "WHO" Patient Safety Solutions: Where Do We Stand and What Can We Do?
    Banihashemi, Sheida
    Hatam, Nahid
    Zand, Farid
    Kharazmi, Erfan
    Nasimi, Soheila
    Askarian, Mehrdad
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2015, 6
  • [3] Ibuprofen and cardiovascular safety: Where do we stand?
    Purcell, Henry
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2007, 100 : 7 - 10
  • [4] The issue of statin safety - Where do we stand?
    Grundy, SM
    CIRCULATION, 2005, 111 (23) : 3016 - 3019
  • [5] The computerized patient record: Where do we stand?
    Jaspers, M. W. M.
    Knaup, P.
    Schmidt, D.
    METHODS OF INFORMATION IN MEDICINE, 2006, 45 : 29 - 39
  • [6] Patient engagement with the BJD: where do we stand?
    Arents, B. W. M.
    Burton, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : 601 - 602
  • [7] Patient's rights: Where do we stand?
    Kozuh, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [8] The safety and efficacy of apixaban: where do we stand in 2013?
    Brito, Flavio de Souza
    Lopes, Renato D.
    Alexander, John H.
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (04) : 559 - 567
  • [9] The safety assessment of proteins in food: where do we stand?
    Dumont, A. Fernandez
    Paoletti, C.
    Ruiz, J. Gomez
    Ardizzone, M.
    Lanzoni, A.
    TOXICOLOGY LETTERS, 2018, 295 : S140 - S141
  • [10] Where do we stand?
    Thompson, ID
    FORESTRY CHRONICLE, 2003, 79 (03): : 381 - 382